Young Adult Patients with Post -HCT Relapse of AML May Benefit from Aggressive Salvage and 2nd Cellular Therapy
Ahmed, Syed Osman, Gamil, Amna, Almahayni, Muhamad Hitham, Chaudhri, Naeem A., Alsharif, Fahad, Mohamad, Said Y, Alzahrani, Hazza A, Rasheed, Walid, Aldawsari, Ghuzayel, Hanbali, Amr, Shaheen, Marwan, Alfraih, Feras, Ahmed, Shad, Ibrahim, Khaled, Almhareb, Fahed, Aljurf, Mahmoud
Published in Blood (03.12.2015)
Published in Blood (03.12.2015)
Get full text
Journal Article
Real-World Data Indicates That the Addition of Etoposide to Idarubicin and Cytarabine (3+7) Induction in Young Adults (<60 years) with AML Does Not Improve Survival or Remission Rates
Ahmed, Syed Osman, Almohareb, Fahad, Aljurf, Mahmoud, Alhussinan, Modhi, Bawazeer, Dalal, Alzahrani, Hazza A, Alsharif, Fahad Z., Mohamad, Said Y, Hanbali, Amr, Alfraih, Feras, Shaheen, Marwan, El Fakih, Riad O., Hashmi, Shahrukh, Almahayni, Muhamad Hitham, Al Ahmari, Ali, Ahmed, Shad, Chebbo, Wahiba, Alotaibi, Ahmad Salih, Mannan, Abdul, el Gohary, Ghada, Ali, Osama, Alsermani, Maamoun, Anjum, Farhan, Aljuhani, Ghada, Hussain, Fazal, Chaudhri, Naeem A., Rasheed, Walid
Published in Blood (02.12.2016)
Published in Blood (02.12.2016)
Get full text
Journal Article